10.6084/m9.figshare.9969263.v1 Fujun Li Fujun Li Lixia Miao Lixia Miao Teng Xue Teng Xue Hao Qin Hao Qin Santanu Mondal Santanu Mondal Paul Thompson Paul Thompson Scott Coonrod Scott Coonrod Xiaoqiu Liu Xiaoqiu Liu Xuesen Zhang Xuesen Zhang MOESM7 of Inhibiting PAD2 enhances the anti-tumor effect of docetaxel in tamoxifen-resistant breast cancer cells Springer Nature 2019 Breast cancer Tamoxifen-resistance PAD2 Docetaxel 2019-10-11 05:37:29 Journal contribution https://springernature.figshare.com/articles/journal_contribution/MOESM7_of_Inhibiting_PAD2_enhances_the_anti-tumor_effect_of_docetaxel_in_tamoxifen-resistant_breast_cancer_cells/9969263 Additional file 7. Figure S7. Western blot analysis showing that pretreatment of PAD2 knockdown (a) or miR-125b-5p overexpression (b) MCF7/TamR cells with 10 ÎźM MHY1485 abolished the inhibitory effect of docetaxel on Rps6 activation. GAPDH served as loading control; shPAD2: PAD2 knockdown MCF7/TamR cells; miR-125b-5p: miR-125b-5p overexpression MCF7/TamR cells; Doc: docetaxel; PBS was used as a control.